| Large spectrum of HLA-C recognition by killer Ig–like receptor (KIR) 2DL2 and KIR2DL3 and restricted C1 specificity of KIR2DS2: dominant impact of KIR2DL2/KIR2DS2 on KIR2D NK … G David, Z Djaoud, C Willem, N Legrand, P Rettman, K Gagne, A Cesbron, ... The Journal of Immunology 191 (9), 4778-4788, 2013 | 109 | 2013 |
| KIR2DS2 recognizes conserved peptides derived from viral helicases in the context of HLA-C MM Naiyer, SA Cassidy, A Magri, V Cowton, K Chen, S Mansour, ... Science immunology 2 (15), eaal5296, 2017 | 99 | 2017 |
| Amplified NKG2C+ NK cells in cytomegalovirus (CMV) infection preferentially express killer cell Ig-like receptor 2DL: functional impact in controlling CMV-infected dendritic cells Z Djaoud, G David, C Bressollette, C Willem, P Rettman, K Gagne, ... The Journal of Immunology 191 (5), 2708-2716, 2013 | 60 | 2013 |
| Activity of IL-12/15/18 primed natural killer cells against hepatocellular carcinoma L Zhuang, RJ Fulton, P Rettman, AE Sayan, J Coad, A Al-Shamkhani, ... Hepatology international 13, 75-83, 2019 | 46 | 2019 |
| Both the nature of KIR3DL1 alleles and the KIR3DL1/S1 allele combination affect the KIR3DL1 NK‐cell repertoire in the French population K Gagne, C Willem, N Legrand, Z Djaoud, G David, P Rettman, ... European Journal of Immunology 43 (4), 1085-1098, 2013 | 37 | 2013 |
| Peptide: MHC-based DNA vaccination strategy to activate natural killer cells by targeting killer cell immunoglobulin-like receptors P Rettman, MD Blunt, RJ Fulton, AF Vallejo, LY Bastidas-Legarda, ... Journal for Immunotherapy of Cancer 9 (5), 2021 | 12 | 2021 |
| New insights on the natural killer cell repertoire from a thorough analysis of cord blood cells P Rettman, C Willem, G David, R Riou, N Legrand, J Esbelin, A Cesbron, ... Journal of Leucocyte Biology 100 (3), 471-479, 2016 | 11 | 2016 |
| A novel antibody combination to identify KIR2DS2high natural killer cells in KIR2DL3/L2/S2 heterozygous donors MD Blunt, P Rettman, LY Bastidas‐Legarda, R Fulton, V Capizzuto, ... Hla 93 (1), 32-35, 2019 | 9 | 2019 |
| Impact of KIR/HLA genetic combinations on double umbilical cord blood transplantation outcomes. Results of a French multicentric retrospective study on behalf of the Société … P Rettman, F Malard, N Legrand, O Avinens, JF Eliaou, C Picard, ... Bone Marrow Transplantation 51 (11), 1499-1503, 2016 | 9 | 2016 |
| Use of killer cell immunoglobulin-like receptor genes as early markers of hematopoietic chimerism after double-umbilical cord blood transplantation P Rettman, N Legrand, C Willem, L Lodé, P Chevallier, A Cesbron, ... haematologica 100 (11), e475, 2015 | 9 | 2015 |
| Impact of graft-versus-graft natural killer cell alloreactivity on single unit dominance after double umbilical cord blood transplantation P Rettman, C Willem, C Volteau, N Legrand, P Chevallier, L Lodé, ... Transplantation 101 (9), 2092-2101, 2017 | 8 | 2017 |
| Peptide: MHC dependent activation of natural killer cells through KIR2DS2 generates anti-tumor responses P Rettman, MD Blunt, B Mbiribindi, R Fulton, RB Schittenhelm, AV Pulido, ... bioRxiv, 2020.04. 15.042077, 2020 | 2 | 2020 |
| Evaluation of NK cell combination therapies in mouse models of cancer K Franciszkiewicz, P Rettman, B Gauthier, L Noblet, C Nicolazzi, A Kunert, ... Cancer Research 84 (6_Supplement), 1334-1334, 2024 | | 2024 |
| NK-humanized mouse models for the in vivo evaluation of NK cell-based therapies in solid tumors P Rettman, S Benhamouche-Trouillet, M Pelat, K Franciszkiewicz, G Azar, ... Cancer Research 84 (6_Supplement), 5340-5340, 2024 | | 2024 |
| Pre-clinical development of a novel anti-GPRC5D inducing potent anti-tumor effect through enhanced antibody-dependent cell-mediated cytotoxicity (ADCC) for multiple myeloma H Bonnevaux, E Remy, T Pizette, S Bouvier, K Desrumeaux, L Bassinet, ... Cancer Research 84 (6_Supplement), 2727-2727, 2024 | | 2024 |
| Use of NK humanized mouse models for the in vivo evaluation of anti-tumor NK-cell therapies P Rettman, LM Meyer, R Rangara, A Ponchet-Lac, N Moindrot, ... Cancer Research 83 (7_Supplement), 2940-2940, 2023 | | 2023 |
| Development of NK humanized mice models for the in vivo evaluation of NK cell engagers P Rettman, D Bourges, LM Meyer, R Rangara, A Ponchet-Lac, N Moindrot, ... Cancer Research 82 (12_Supplement), 4247-4247, 2022 | | 2022 |
| Natural killer cells target XPO1: a therapeutic opportunity for HCC P Rettman, M Blunt, L Bastidas-Legarda, R Fulton, R Schittenhelm, ... Journal of Hepatology 73, S647-S648, 2020 | | 2020 |
| A DNA vaccine strategy to activate natural killer cells for therapeutic targeting of XPO1-positive tumors P Rettman, MD Blunt, B Mbiribindi, R Fulton, RB Schittenhelm, AV Pulido, ... bioRxiv, 2020 | | 2020 |
| Multidimensional reduction of multicentric cohort heterogeneity: An alternative method to increase statistical power and robustness C Le Gall, J Laurent, N Vince, A Lizee, A Agrawal, A Walencik, P Rettman, ... Human Immunology 77 (11), 1024-1029, 2016 | | 2016 |
